Passer au contenu principal

pyruvate kinase L/R

La PKLR gene is active (expressed) in the liver and in red blood cells, where it provides instructions for producing an enzyme called pyruvate kinase. This enzyme is involved in a critical energy-producing process known as glycolysis. During glycolysis, the simple sugar glucose is broken down to produce energy. Specifically, pyruvate kinase is involved in the last step of the glycolytic pathway. In this step, a cluster of oxygen and phosphorus atoms (a phosphate group) is moved from a molecule called phosphoenolpyruvate to another molecule called adenosine diphosphate (ADP), resulting in molecules called pyruvate and adenosine triphosphate (ATP). ATP is the cell's main energy source.

Sélections vidéo pour Gènes
Bibliothèque vidéo

Normal function

La PKLR gene is active (expressed) in the liver and in red blood cells, where it provides instructions for producing an enzyme called pyruvate kinase. This enzyme is involved in a critical energy-producing process known as glycolysis. During glycolysis, the simple sugar glucose is broken down to produce energy. Specifically, pyruvate kinase is involved in the last step of the glycolytic pathway. In this step, a cluster of oxygen and phosphorus atoms (a phosphate group) is moved from a molecule called phosphoenolpyruvate to another molecule called adenosine diphosphate (ADP), resulting in molecules called pyruvate and adenosine triphosphate (ATP). ATP is the cell's main energy source.

Conditions referring to this gene or chromosome

Other names

KPYR_HUMAN

PK1

PKL

PKR

PKRL

pyruvate kinase 1

pyruvate kinase isozyme R/L

pyruvate kinase type L

pyruvate kinase, liver and blood cell

pyruvate kinase, liver and RBC

R-type/L-type pyruvate kinase

red cell/liver pyruvate kinase

RPK

Related patient information and medicines

Anémie

Patient information leaflet

Anémie

Anaemia means that you have fewer red blood cells than normal or you have less haemoglobin than normal in each red blood cell. Conditions where there are haemoglobin abnormalities such as sickle cell anaemia Sickle cell disease or thalassaemia Thalassaemia - these are discussed below. And problems with the chemicals (or enzymes) that help the.

Maladies de stockage du glycogène

Patient information leaflet

Maladies de stockage du glycogène

Maladies de stockage du glycogène are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. A blood test to measure a substance called créatine kinase can give information about whether the glycogen storage.

Tests de fonction hépatique

Patient information leaflet

Tests de fonction hépatique

The usual liver fonction tests typically include the following: Bilirubine. Albumin. Total protein. Low levels of total protein can sometimes be seen in severe liver disease, in conditions of severe protein loss (such as widespread burns) and in severe malnutrition. What does an abnormal ALT (SGPT), AST (SGOT) or creatine kinase level mean. These.

Cancer de la bouche

Patient information leaflet

Cancer de la bouche

Epidermal growth factor receptor monoclonal antibody (EGFR mAb) is one form of targeted therapy. Cetuximab is an EGFR mAb. Tyrosine kinase inhibitors (TKIs) are another. Immunotherapy is treatment that aims to boost the body's own immune system to destroy the cancer cells. It is also sometimes called biological therapy: Recombinant interleukin.

Arthrite juvénile idiopathique

Patient information leaflet

Arthrite juvénile idiopathique

As they are relatively new medicines, there are still studies being done to establish whether there are any long-term health risks from taking them. Options include: Etanercept Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is another new drug. It belongs to a type of drug called JAK kinase inhibitors. It is sometimes used if.

Cancer primitif du foie

Patient information leaflet

Cancer primitif du foie

In primary un cancer du foie le cancer starts in the liver. In secondary liver cancer, the cancer spreads from another part of the body to the liver. Primary liver cancer is uncommon in the UK but is common in other parts of the world. In the UK, most cases develop as a complication of scarring of the liver (cirrhosis). In general the outlook is poor..

Lectures complémentaires et références

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 18 Aug 2020 | Dernière version
  • 1 Apr 2012 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Pharmacie en ligne, traitements et services de santé

Accès simple à des traitements fiables et à des services de santé en ligne.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.